Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators - PubMed (original) (raw)
- PMID: 6111365
Free article
Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
B T Mellion et al. Blood. 1981 May.
Free article
No abstract available
Similar articles
- Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY, Belushkina NN, Tyshchuk IA, Severina IS, Horowitz JD. Chirkov YY, et al. Clin Exp Pharmacol Physiol. 1991 Jul;18(7):517-24. doi: 10.1111/j.1440-1681.1991.tb01486.x. Clin Exp Pharmacol Physiol. 1991. PMID: 1680588 - Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
Gambaryan S, Subramanian H, Rukoyatkina N, Herterich S, Walter U. Gambaryan S, et al. Thromb Haemost. 2013 May;109(5):973-5. doi: 10.1160/TH12-12-0916. Epub 2013 Mar 7. Thromb Haemost. 2013. PMID: 23467662 No abstract available. - Increase in activating ability of human platelet guanylate cyclase during aggregation.
Severina IS, Belushkina NN. Severina IS, et al. Biochem Int. 1992 Dec;28(4):621-31. Biochem Int. 1992. PMID: 1362351 - Soluble guanylyl cyclase and platelet function.
Buechler WA, Ivanova K, Wolfram G, Drummer C, Heim JM, Gerzer R. Buechler WA, et al. Ann N Y Acad Sci. 1994 Apr 18;714:151-7. doi: 10.1111/j.1749-6632.1994.tb12039.x. Ann N Y Acad Sci. 1994. PMID: 7912486 Review. No abstract available. - [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
Severina IS. Severina IS. Biull Eksp Biol Med. 1995 Mar;119(3):230-5. Biull Eksp Biol Med. 1995. PMID: 7795182 Review. Russian. No abstract available.
Cited by
- Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.
Nossaman B, Pankey E, Kadowitz P. Nossaman B, et al. Crit Care Res Pract. 2012;2012:290805. doi: 10.1155/2012/290805. Epub 2012 Feb 28. Crit Care Res Pract. 2012. PMID: 22482042 Free PMC article. - Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
Hsu CP, Zhao JF, Lin SJ, Shyue SK, Guo BC, Lu TM, Lee TS. Hsu CP, et al. J Am Heart Assoc. 2016 Apr 18;5(4):e003327. doi: 10.1161/JAHA.116.003327. J Am Heart Assoc. 2016. PMID: 27091343 Free PMC article. Clinical Trial. - Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW, Palmer RM, Moncada S. Radomski MW, et al. Br J Pharmacol. 1990 Oct;101(2):325-8. doi: 10.1111/j.1476-5381.1990.tb12709.x. Br J Pharmacol. 1990. PMID: 1701676 Free PMC article. - Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease.
Deeb RS, Lamon BD, Hajjar DP. Deeb RS, et al. Curr Hypertens Rev. 2009 Nov 1;5(4):273-282. doi: 10.2174/157340209789587726. Curr Hypertens Rev. 2009. PMID: 20368751 Free PMC article. - Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
Lidbury PS, Antunes E, de Nucci G, Vane JR. Lidbury PS, et al. Br J Pharmacol. 1989 Dec;98(4):1275-80. doi: 10.1111/j.1476-5381.1989.tb12674.x. Br J Pharmacol. 1989. PMID: 2482103 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources